-
-
-
For cancer patients who have exhausted all available treatment options, Phase I research trials of new oncology drugs may be their only hope. But does that hope come at too high a price?
-
Would your ethics committee approve a request to perform nontherapeutic surgery that would permanently alter the body of a healthy patient without his or her consent? What if the patient was very young and the parents wanted the surgery for religious or cultural reasons?
-
The privacy regulations enacted as part of the federal Health Insurance Portability and Accountability Act (HIPAA) have caused some unforeseen complications for hospitals trying to ensure patient safety and improve communication between providers and patients, say health care professionals and legal experts.
-
Updated EMTALA rule eases hospitals risk; Johns Hopkins program loses its accreditation; AMA to provide ethics alerts to MDs
-
The National Center for Research Resources (NCRR) of Bethesda, MD, established several years ago the role of research subject advocates (RSAs) for the purpose of providing an additional level of monitoring for research projects involving human subjects.
-
The four-year-old Goodwyn IRB of Cincinnati has a unique challenge when its time for the board to meet and discuss protocols because the members are scientific and ethical experts who are spread out across North America.
-
The four-year-old Goodwyn IRB of Cincinnati has a unique challenge when its time for the board to meet and discuss protocols because the members are scientific and ethical experts who are spread out across North America.
-
One of the major fraud prevention efforts over the past decade has been the development and publication of compliance program guidance (CPG) for various aspects of the health care industry. Most recently, we have seen this effort with respect to the pharmaceutical industry and a focus on its relationship to health care providers.
